Abstract
Background Twenty-two Arab countries share a common language, history, and culture. Nevertheless, governmental policies, healthcare systems, and resources differ from one Arab country to another. We have been following Coronavirus (COVID-19) from the beginning in each Arab country. In the present study, we aimed to assess the prevalence of COVID-19 in the Arab world and to compare these findings with other significantly affected countries. Methods Websites of the World Health Organization, World COVID-vaccinations tracker, Worldometer, and Ministries of Health were used to extract COVID-19 data in all Arab countries between the period January 2020 to December 2022. Results All Arab countries had 14,218,042 total confirmed COVID-19 cases, 13,384,924 total recovered cases and 173,544 total related deaths. The trend demonstrated that the third quarter of 2021 recorded the highest death toll and the first quarter of 2022 recorded the highest number of confirmed and recovered cases. Compared to the top 15 affected countries, the Arab world ranked last as it had the lowest overall incidence per million population (PMP) of 31,609. The data on total deaths PMP showed that India had the lowest number of deaths with only 377 cases followed by the Arab world with 386 cases. Conclusions Although the number of confirmed, death, and recovered cases of COVID-19 have greatly reduced in the last quarter of 2022 in most Arab countries, many Arab countries still need to re-campaign about COVID-19 vaccines and raise awareness programs about boosters. COVID-19 has had a relatively smaller impact on Arab countries than on other countries that have been significantly affected.
Reference62 articles.
1. Full-genome evolutionary analysis of the novel corona virus (2019- nCoV) rejects the hypothesis of emergence as a result of a recent recombination event.;D Paraskevis;Infect. Genet. Evol.,2020
2. Prevalence of Asymptomatic SARS-CoV-2 Infection: A Narrative Review.;D Oran;Ann. Intern. Med.,2020
3. Large-scale IgM and IgG SARS-CoV-2 serological screening among healthcare workers with a low infection prevalence based on nasopharyngeal swab tests in an Italian university hospital: Perspectives for public health.;L Vimercati;Environ. Res.,2021
4. The economic value of vaccination: why prevention is wealth.;M Tourni;J. Mark Access Health Policy.,2015
5. Global advisory committee on vaccine safety, 3-4 Dec 2003.;Weekly Epidemiological Rec.,2004